View source for CTSC:BIDresources

[[Collaboration:Harvard_CTSC|Back to CTSC imaging consortium workspace]]  

=Resources and Facilities: Radiology Department=

=Overview=
At Beth Israel Deaconess Medical Center, we offer a complete array of radiologic tests. The Department of Radiology is committed to implementing cutting edge technologies for better patient care. The Radiology Department performs over 400,000 radiologic examinations each year. The department provides radiography, CT, ultrasound, MRI, nuclear medicine, angiography, and interventional radiology services to both the medical center as well as our affiliated health care facilities. A radiology research and animal laboratory is housed adjacent to the Radiology Department. There are over 65 full-time clinical diagnostic radiologists, 20 additional research faculty members, plus 30 clinical and post-doctoral research fellows. All residents, fellows, and faculty have appointments at Harvard Medical School.

=Imaging Facilities=
*[[CTSC:BIDMCresources:MRI|MRI Facilities]]
*[[CTSC:BIDMCresources:CT|CT Facilities]]
*[[CTSC:BIDMCresources:US|US Facilities]]
*[[CTSC:BIDMCresources:nuclear medicine|Nuclear Medicine]]

=Additional Research Centers and Laboratories=

* '''Center for Imaging Technology and Molecular Diagnostics (CITMD)'''
A key area of interdisciplinary research, the CITMD is an interdepartmental center at the BIDMC. The co-founders of the CITMD are Robert E. Lenkinski, Ph.D., Professor of Radiology, and John V. Frangioni, M.D., Ph.D., Associate Professor of Medicine and Associate Professor of Radiology, both at Harvard Medical School. These laboratories ([http://research.bidmc.harvard.edu/research/ResearchPIInfo.ASP?Submit=Display&PersonID=863 Lenkinski lab], [http://www.FrangioniLab.org Frangioni lab] ) have been active in the field of molecular imaging since 1999, and are the recipients of multiple NIH, industry, and foundation peer-reviewed grants. Three years ago, the CITMD began building a small animal imaging facility (http://www.longwoodsaif.org/), which has now blossomed into a state-of-the-art center.  These services include multi-modality imaging, advanced data analysis, image fusion resources, and a satellite animal facility for longitudinal studies. The CITMD is establishing a first-in-human clinical trials infrastructure to translate new cancer detection technologies into the clinic for testing on patients. This structure will ensure that promising contrast agents and imaging technology are tested on patients in a safe, efficient manner.
* '''Laboratory for Functional Imaging of Cartilage'''
Nondestructive techniques for accurately assessing the structural and functional integrity of cartilage are essential for defining the natural history of arthritis and for evaluating the effects of prevention and therapeutic interventions. Our long-term goal is to establish magnetic resonance imaging (MRI) techniques for evaluating the compositional and functional integrity of articular cartilage. Contact: e-mail [mailto:dburstei@bidmc.harvard.edu Dr Deborah Burstein]
* '''In Vivo Optical Imaging Laboratory'''
The In Vivo Optical Imaging Laboratory has made several significant advances  both at the micro- and macroscopic levels.<br>
- the whole-animal optical imaging system is now fully functional and has the ability to image live animals throughout the entire spectrum from visible to the near-infrared light. <br>
- the optical microscopy laboratory has continued to explore individual molecular events during formation of liver metastases from human colon cancer, and has documented the sequence of events leading to onset of angiogenesis in these liver tumors. A new and very exciting focus has been the use of conventional ultrasound to enhance delivery of drugs into liver metastases.<br>
Contact: e-mail [mailto:mpalmer@bidmc.harvard.edu Dr Matt Palmer]